A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Main|Search|PHGKB




Last Posted: Jul 19, 2018

---

• A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.  
  Niihara Yutaka et al. The New England journal of medicine 2018 Jul (3) 226-235
• l-Glutamine and the Dawn of Combination Therapy for Sickle Cell Disease.  
  Minniti Caterina P et al. The New England journal of medicine 2018 Jul (3) 292-294
• Cancer Scientists Have Ignored African DNA in the Search for Cures  
  J Wapner, Newsweek, July 2018
• Adapting medical guidelines to be patient-centered using a patient-driven process for individuals with sickle cell disease and their caregivers.  
  Cronin Robert Michael et al. BMC hematology 2018 1812
• Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.  
  Nguyen-Khoa Thao et al. Annales de biologie clinique 2018 Jul
• MANAGEMENT OF PATIENTS WITH SICKLE CELL DISEASE IN ORAL SURGERY: Literature Review and Update.  
  Prevost Raphaelle et al. Journal of stomatology, oral and maxillofacial surgery 2018 Jun
• Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).  
  Baumann Ana A et al. BMC health services research 2018 Jun 18(1) 500
• Are Payers Ready To Address The Financial Challenges Associated With Gene Therapy?  
  Health Affairs Blog, June 28, 2018
• Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease.  
  Raffield Laura M et al. PLoS genetics 2018 14(3) e1007293
• [Awareness and attitudes of 50 congolese families affected by sickle cell disease: a local survey].  
  Mukinayi Benoît Mbiya et al. The Pan African medical journal 2018 2924

more